Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	142.15	374.04	240.94	409.25	191.98
Short-Term Investments	165.43	79.94	130.94	-	-
Cash & Short-Term Investments	307.58	453.98	371.88	409.25	191.98
Cash Growth	-32.25%	22.08%	-9.13%	113.17%	-
Other Receivables	-	-	0.92	0.2	0.15
Receivables	-	-	0.92	0.2	0.15
Prepaid Expenses	5.26	18	1.62	1.2	0.78
Restricted Cash	1.21	-	0.05	0.13	0.13
Other Current Assets	-	6.3	13.48	4.84	0.81
Total Current Assets	314.06	478.28	387.96	415.6	193.84
Property, Plant & Equipment	2.92	6.86	10.64	4.04	3.92
Long-Term Investments	-	9.85	23.51	-	-
Long-Term Deferred Charges	-	-	2.9	1.83	-
Other Long-Term Assets	-	1.21	1.23	7.82	0.18
Total Assets	316.97	496.2	426.23	429.3	197.95
Accounts Payable	3.31	0.34	7.15	1.64	2.4
Accrued Expenses	24.59	21.26	11.54	19.1	5.6
Current Portion of Leases	1.85	3.38	3.37	1.06	0.76
Other Current Liabilities	0.13	0.14	1.64	1.49	0.61
Total Current Liabilities	29.89	25.11	23.7	23.28	9.37
Long-Term Leases	-	1.85	5.07	1	1.28
Other Long-Term Liabilities	0.02	0.16	0.63	0.39	-
Total Liabilities	29.91	27.12	29.4	24.66	10.65
Common Stock	0.02	0.02	0	0.01	0.01
Additional Paid-In Capital	1,234	1,173	21.43	11.37	4.9
Retained Earnings	-947.22	-703.43	-467.51	-336.61	-99.29
Comprehensive Income & Other	0.06	-0.08	-0.77	-	-
Total Common Equity	287.06	469.08	-446.85	-325.22	-94.38
Shareholders' Equity	287.06	469.08	396.84	404.64	187.3
Total Liabilities & Equity	316.97	496.2	426.23	429.3	197.95
Total Debt	1.85	5.23	8.44	2.05	2.05
Net Cash (Debt)	305.73	458.6	386.95	407.2	189.93
Net Cash Growth	-33.34%	18.52%	-4.97%	114.39%	-
Net Cash Per Share	1.92	7.05	14.22	18.60	14.61
Filing Date Shares Outstanding	161.98	158.89	32.61	31.98	30.61
Total Common Shares Outstanding	161.71	158.83	32.61	31.98	30.61
Working Capital	284.17	453.17	364.26	392.33	184.47
Book Value Per Share	1.78	2.95	-13.70	-10.17	-3.08
Tangible Book Value	287.06	469.08	-446.85	-325.22	-94.38
Tangible Book Value Per Share	1.78	2.95	-13.70	-10.17	-3.08
Machinery	3.19	3.18	2.94	2.3	1.83
Construction In Progress	-	0.04	0.51	0.22	-
Leasehold Improvements	-	-	0.02	0.26	0.21

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q